Content about Palsy

April 17, 2014

Recognizing its dedication to the employment of persons with disabilities, United Cerebral Palsy on Thursday named Meijer “Employer of the Year.”

GRAND RAPIDS, Mich. — Recognizing its dedication to the employment of persons with disabilities, United Cerebral Palsy on Thursday named Meijer “Employer of the Year.” The 2014 Award for Excellence, announced at UCP’s Annual Conference in Nashville, Tenn., demonstrates the retailer’s steadfast commitment to diversity while helping people with disabilities reach their full potential through meaningful employment at Meijer. 

December 18, 2012

Drug maker Merz Pharmaceuticals is suing Par Pharmaceutical over the latter's attempt to market a generic drug for cerebral palsy patients, according to published reports.

NEW YORK — Drug maker Merz Pharmaceuticals is suing Par Pharmaceutical over the latter's attempt to market a generic drug for cerebral palsy patients, according to published reports.

Bloomberg reported that Merz sued Par in the U.S. District Court for the District of Delaware after Par attempted to apply for Food and Drug Administration approval for a generic version of Cuvposa (glycopyrrolate) oral solution, used to treat severe drooling in cerebral palsy patients.

The drug received FDA approval this year, and Merz bought rights to the drug in August.

August 28, 2012

Merz announced it has acquired a medication designed to treat a condition associated with such neurologic conditions as cerebral palsy.

GREENSBORO, N.C. — Merz announced it has acquired a medication designed to treat a condition associated with such neurologic conditions as cerebral palsy.